Silymarin- and melatonin-mediated changes in the expression of selected genes in pesticides-induced Parkinsonism

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2013-08-22

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s11010-013-1780-xPMID 23963992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease.

  2013cited by this paper
• Cypermethrin Alters the Expression Profile of mRNAs in the Adult Rat Striatum: A Putative Mechanism of Postnatal Pre-exposure Followed by Adulthood Re-exposure-Enhanced Neurodegeneration

  2012cited by this paper
• Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling.

  2012cited by this paper
• Vitamin E Inhibits Oxidative Stress-Induced Denaturation of Nerve Terminal Proteins Involved in Neurotransmission

  2012cited by this paper
• Melatonin Antioxidative Defense: Therapeutical Implications for Aging and Neurodegenerative Processes

  2012cited by this paper
• Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse.

  2012cited by this paper
• Role of Secondary Mediators in Caffeine-Mediated Neuroprotection in Maneb- and Paraquat-Induced Parkinson’s Disease Phenotype in the Mouse

  2012cited by this paper
• Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood.

  2012cited by this paper
• Rodent Models and Contemporary Molecular Techniques: Notable Feats yet Incomplete Explanations of Parkinson’s Disease Pathogenesis

  2012cited by this paper
• Somatodendritic Dopamine Release Requires Synaptotagmin 4 and 7 and the Participation of Voltage-gated Calcium Channels*

  2011cited by this paper
• Melatonin as a Neuroprotective Agent in the Rodent Models of Parkinson’s Disease: Is it All Set to Irrefutable Clinical Translation?

  2011cited by this paper
• Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and -independent regulations.

  2011cited by this paper
• Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death

  2011cited by this paper
• Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury.

  2011cited by this paper
• Involvement of multiple molecular events in pyrogallol-induced hepatotoxicity and silymarin-mediated protection: evidence from gene expression profiles.

  2010cited by this paper
• Effect of zinc and paraquat co-exposure on neurodegeneration: Modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats

  2010cited by this paper
• Antiinflammatory Activity of Melatonin in Central Nervous System

  2010cited by this paper
• Nicotine- and caffeine-mediated changes in gene expression patterns of MPTP-lesioned mouse striatum: Implications in neuroprotection mechanism.

  2010cited by this paper
• Proteomics in Parkinson’s disease: current trends, translational snags and future possibilities

  2010cited by this paper
• Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling

  2010cited by this paper
• Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress.

  2010cited by this paper
• Melatonin or silymarin reduces maneb‐ and paraquat‐induced Parkinson’s disease phenotype in the mouse

  2010cited by this paper
• Melatonin synergistically increases resveratrol‐induced heme oxygenase‐1 expression through the inhibition of ubiquitin‐dependent proteasome pathway: a possible role in neuroprotection

  2010cited by this paper
• Gene expression profiling in progressively MPTP-lesioned macaques reveals molecular pathways associated with sporadic Parkinson's disease.

  2010cited by this paper
• Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-κB and STAT-1 activation.

  2010cited by this paper
• Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease.

  2010cited by this paper
• Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma-glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity.

  2010cited by this paper
• Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.

  2009cited by this paper
• Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps

  2009cited by this paper
• Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease.

  2008cited by this paper
• Maneb potentiates paraquat neurotoxicity by inducing key Bcl‐2 family members

  2008cited by this paper
• Gene Expression Profiles of Mouse Striatum in Control and Maneb + Paraquat-induced Parkinson’s Disease Phenotype: Validation of Differentially Expressed Energy Metabolizing Transcripts

  2008cited by this paper
• Protective effect of silymarin on oxidative stress in rat brain.

  2007cited by this paper
• Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome.

  2007cited by this paper
• The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system.

  2007cited by this paper
• Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration.

  2006cited by this paper
• Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease.

  2006cited by this paper
• Cell death in the nervous system

  2006cited by this paper
• Effects of prenatal paraquat and mancozeb exposure on amino acid synaptic transmission in developing mouse cerebellar cortex.

  2005cited by this paper
• Inflammatory process in Parkinson's disease: role for cytokines.

  2005cited by this paper
• Silymarin protects dopaminergic neurons against lipopolysaccharide‐induced neurotoxicity by inhibiting microglia activation

  2002cited by this paper
• GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways

  2002cited by this paper
• Cytokine-mediated neuronal apoptosis.

  1997cited by this paper
• Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors.

  1995cited by this paper
• The melatonin rhythm: both a clock and a calendar

  1993cited by this paper

• An update on the involvement of inflammatory mediators in Parkinson’s disease pathogenesis

  2025cites this paper
• Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer’s Disease and Other Neurological Disorders

  2025cites this paper
• Unlocking the Possibilities of Therapeutic Potential of Silymarin and Silibinin against Neurodegenerative Diseases-A Mechanistic Overview.

  2024cites this paper
• Silibinin chronic treatment in a rat model of Parkinson disease: A comprehensive in-vivo evaluation and in silico molecular modeling.

  2023cites this paper
• Exposure to the environmentally toxic pesticide maneb induces Parkinson's disease-like neurotoxicity in mice: A combined proteomic and metabolomic analysis.

  2022cites this paper
• Tempol and silymarin rescue from zinc-induced degeneration of dopaminergic neurons through modulation of oxidative stress and inflammation

  2022cites this paper
• Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms.

  2022cites this paper
• Cyclooxygenase-2 activates the free radical-mediated apoptosis of polymorphonuclear leukocytes in the maneb- and paraquat-intoxicated rats.

  2022cites this paper
• Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.

  2020cites this paper
• Silymarin Protects Against Impaired Autophagy Associated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinsonism

  2019cites this paper
• Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing

  2018cites this paper
• Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats.

  2018cites this paper
• Developmental Programming of Adult Disease: Reprogramming by Melatonin?

  2017cites this paper
• A review of the protective effect of melatonin in pesticide-induced toxicity

  2017cites this paper
• Antioxidants Against Environmental Factor-Induced Oxidative Stress

  2017cites this paper
• Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

  2016cites this paper
• IFN-γ regulates xanthine oxidase-mediated iNOS-independent oxidative stress in maneb- and paraquat-treated rat polymorphonuclear leukocytes

  2016cites this paper
• Silymarin attenuates paraquat‐induced lung injury via Nrf2‐mediated pathway in vivo and in vitro

  2015cites this paper
• Withania somnifera Alleviates Parkinsonian Phenotypes by Inhibiting Apoptotic Pathways in Dopaminergic Neurons

  2014cites this paper
• Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.

  2014cites this paper